BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21771129)

  • 1. To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes.
    Molina-Barceló A; Salas Trejo D; Peiró-Pérez R; Málaga López A
    Eur J Cancer Care (Engl); 2011 Sep; 20(5):669-78. PubMed ID: 21771129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informed decision-making and colorectal cancer screening: is it occurring in primary care?
    Ling BS; Trauth JM; Fine MJ; Mor MK; Resnick A; Braddock CH; Bereknyei S; Weissfeld JL; Schoen RE; Ricci EM; Whittle J
    Med Care; 2008 Sep; 46(9 Suppl 1):S23-9. PubMed ID: 18725829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening: how to help patients comply.
    Goldsmith G; Chiaro C
    J Fam Pract; 2008 Jul; 57(7):E2-7. PubMed ID: 18625166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study.
    García M; Borràs JM; Milà N; Espinàs JA; Binefa G; Fernández E; Farré A; Pla M; Cardona A; Moreno V
    Prev Med; 2011; 52(3-4):265-7. PubMed ID: 21295061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15.
    Walsh B; Silles M; O'Neill C
    Health Policy; 2011 Aug; 101(3):269-76. PubMed ID: 21420755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening among men and women in the United States.
    Peterson NB; Murff HJ; Ness RM; Dittus RS
    J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial factors associated with the adherence to a colorectal cancer screening program.
    Gili M; Roca M; Ferrer V; Obrador A; Cabeza E
    Cancer Detect Prev; 2006; 30(4):354-60. PubMed ID: 16963195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005.
    Trivers KF; Shaw KM; Sabatino SA; Shapiro JA; Coates RJ
    Am J Prev Med; 2008 Sep; 35(3):185-93. PubMed ID: 18617355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploratory study examining barriers to participation in colorectal cancer screening.
    Paddison JS; Yip MJ
    Aust J Rural Health; 2010 Feb; 18(1):11-5. PubMed ID: 20136809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal cancer: sense and sensibilities.
    Van Hal G; Hoeck S; Van Roosbroeck S
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S156-63. PubMed ID: 21943969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do women who choose not to participate in population-based cervical cancer screening reason about their decision?
    Blomberg K; Ternestedt BM; Törnberg S; Tishelman C
    Psychooncology; 2008 Jun; 17(6):561-9. PubMed ID: 17886262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing participation in colorectal cancer screening-a qualitative study in an ethnic and socio-economically diverse inner city population.
    Dharni N; Armstrong D; Chung-Faye G; Wright AJ
    Health Expect; 2017 Aug; 20(4):608-617. PubMed ID: 27550367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equity of colorectal cancer screening: which groups have inequitable participation and what can we do about it?
    Ward PR; Javanparast S; Wilson C
    Aust J Prim Health; 2011; 17(4):334-46. PubMed ID: 22112702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there gender differences in colorectal cancer test use prevalence and correlates?
    McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors triggering medical consultation for symptoms of colorectal cancer and perceptions surrounding diagnosis.
    Ramos M; Arranz M; Taltavull M; March S; Cabeza E; Esteva M
    Eur J Cancer Care (Engl); 2010 Mar; 19(2):192-9. PubMed ID: 19709162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors.
    Lipkus IM; Green LG; Marcus A
    J Health Commun; 2003; 8(3):213-28. PubMed ID: 12857652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting adequate information across to colorectal cancer screening subjects can be difficult.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Bossuyt PM; Fockens P; Dekker E; Jansen JB
    J Med Screen; 2008; 15(3):149-52. PubMed ID: 18927098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.